John C.K. Milligan, IV
2020
In 2020, John C.K. Milligan, IV earned a total compensation of $2.3M as President and Secretary at TherapeuticsMD, a 58% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,000 |
|---|---|
| Salary | $450,000 |
| Stock Awards | $1,479,105 |
| Other | $31,285 |
| Total | $2,275,390 |
Milligan received $1.5M in stock awards, accounting for 65% of the total pay in 2020.
Milligan also received $315K in non-equity incentive plan, $450K in salary and $31.3K in other compensation.
Rankings
In 2020, John C.K. Milligan, IV's compensation ranked 4,952nd out of 13,090 executives tracked by ExecPay. In other words, Milligan earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,952 out of 13,090 | 62nd |
Division Manufacturing | 2,015 out of 5,624 | 64th |
Major group Chemicals And Allied Products | 800 out of 2,257 | 65th |
Industry group Drugs | 691 out of 1,957 | 65th |
Industry Pharmaceutical Preparations | 519 out of 1,462 | 65th |
Source: SEC filing on April 14, 2021.
Milligan's colleagues
We found two more compensation records of executives who worked with John C.K. Milligan, IV at TherapeuticsMD in 2020.